Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Toogood

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Bone Marrow Transplantation|March 24, 1998
Allogeneic CD34 selected peripheral stem cell transplant for Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI): rapid haemopoietic and biochemical reconstitutionF Alvaro, I Toogood, J M Fletcher, et al.
Journal of Pediatric Hematology/Oncology|February 1, 1995
A prospective study of the psychological adjustment of children with cancerM G Sawyer, G Antoniou, A M Nguyen, et al.
Journal of Paediatrics and Child Health|December 24, 1997
Improvement in outcome of children with Wilms' tumour in South Australia over the last 30 yearsN J Spurrier, I Toogood, R Byard, et al.
Medical and Pediatric Oncology|August 1, 1997
Granulocyte-macrophage colony-stimulating factor in association with high-dose chemotherapy (VETOPEC) for childhood solid tumors: a report from the Australia and New Zealand Children's Cancer Study GroupG B McCowage, L White, P Carpenter, et al.
Journal of Pediatric Hematology/Oncology|April 17, 1998
Postoperative chemotherapy in children less than 4 years of age with malignant brain tumors: promising initial response to a VETOPEC-based regimen. A Study of the Australian and New Zealand Children's Cancer Study Group (ANZCCSG)L White, S Kellie, E Gray, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|December 1, 1996
A 3-year follow-up of the intellectual and academic functioning of children receiving central nervous system prophylactic chemotherapy for leukemiaR T Brown, M B Sawyer, G Antoniou, et al.
Australian and New Zealand Journal of Medicine|June 1, 1986
Immunological reconstitution in a patient with severe combined immune deficiency using non-sibling bone marrow depleted of T cells with HuLy-m1D M Roberton, G M Georgiou, K Tiedemann, et al.
Cancer|December 1, 1994
Excessive spinal cord toxicity from intensive central nervous system-directed therapiesJ Watterson, I Toogood, M Nieder, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Postoperative chemotherapy without radiation in young children with malignant non-astrocytic brain tumours. A report from the Australia and New Zealand Childhood Cancer Study Group (ANZCCSG)L White, H Johnston, R Jones, et al.
Cancer|August 1, 1997
A dose-intensive, cyclophosphamide-based regimen for the treatment of recurrent/progressive or advanced solid tumors of childhood: a report from the Australia and New Zealand Children's Cancer Study GroupP A Carpenter, L White, G B McCowage, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|March 24, 1998
Allogeneic CD34 selected peripheral stem cell transplant for Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI): rapid haemopoietic and biochemical reconstitutionF Alvaro, I Toogood, J M Fletcher, et al.
Journal of Pediatric Hematology/Oncology|February 1, 1995
A prospective study of the psychological adjustment of children with cancerM G Sawyer, G Antoniou, A M Nguyen, et al.
Journal of Paediatrics and Child Health|December 24, 1997
Improvement in outcome of children with Wilms' tumour in South Australia over the last 30 yearsN J Spurrier, I Toogood, R Byard, et al.
Medical and Pediatric Oncology|August 1, 1997
Granulocyte-macrophage colony-stimulating factor in association with high-dose chemotherapy (VETOPEC) for childhood solid tumors: a report from the Australia and New Zealand Children's Cancer Study GroupG B McCowage, L White, P Carpenter, et al.
Journal of Pediatric Hematology/Oncology|April 17, 1998
Postoperative chemotherapy in children less than 4 years of age with malignant brain tumors: promising initial response to a VETOPEC-based regimen. A Study of the Australian and New Zealand Children's Cancer Study Group (ANZCCSG)L White, S Kellie, E Gray, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|December 1, 1996
A 3-year follow-up of the intellectual and academic functioning of children receiving central nervous system prophylactic chemotherapy for leukemiaR T Brown, M B Sawyer, G Antoniou, et al.
Australian and New Zealand Journal of Medicine|June 1, 1986
Immunological reconstitution in a patient with severe combined immune deficiency using non-sibling bone marrow depleted of T cells with HuLy-m1D M Roberton, G M Georgiou, K Tiedemann, et al.
Cancer|December 1, 1994
Excessive spinal cord toxicity from intensive central nervous system-directed therapiesJ Watterson, I Toogood, M Nieder, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Postoperative chemotherapy without radiation in young children with malignant non-astrocytic brain tumours. A report from the Australia and New Zealand Childhood Cancer Study Group (ANZCCSG)L White, H Johnston, R Jones, et al.
Cancer|August 1, 1997
A dose-intensive, cyclophosphamide-based regimen for the treatment of recurrent/progressive or advanced solid tumors of childhood: a report from the Australia and New Zealand Children's Cancer Study GroupP A Carpenter, L White, G B McCowage, et al.
Pageof 4